Evidence map›Paper›PMID 29541793›Full record

ReviewCellular and molecular life sciences : CMLS2018

Nestin-expressing progenitor cells: function, identity and therapeutic implications.

Aurora Bernal, Lorena Arranz

Open access · hybridAbstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 238 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
238citing papers in PubMed, 2 pooled it
17.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

238 citing papers in PubMed, 2 syntheses or guidelines pooled it, 405 citations in OpenAlex.

  1. Pooled it
  2. Nestin Expression and the Survival of Patients With Digestive Tract Cancers: A Systematic Review and Meta-Analysis.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2023
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Engineered NestinJournal of extracellular vesicles · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

178 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Aurora BernalStem Cell Aging and Cancer Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT, The Arctic University of Norway, MH Building Level 6, 9019, Tromsø, Norway.
Lorena ArranzStem Cell Aging and Cancer Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT, The Arctic University of Norway, MH Building Level 6, 9019, Tromsø, Norway. lorena.arranz@uit.no.ORCID 0000-0002-5896-4238
UiT The Arctic University of Norway · NOUniversity Hospital of North Norway · NO

Funding

Aakre-Stiftelsen 2016/9050Helse Nord RHF 2014/5668Helse Nord RHF HNF1338-17Kreftforeningen 6765150Norges Forskningsråd 247596Norges Forskningsråd 250901
6 · The paper itself

Abstract

The neuroepithelial stem cell protein, or Nestin, is a cytoskeletal intermediate filament initially characterized in neural stem cells. However, current extensive evidence obtained in in vivo models and humans shows presence of Nestin

Indexed as

AnimalsCell DifferentiationCell MovementCell ProliferationGene ExpressionHematologic NeoplasmsHumansModels, MolecularNestinNeurodegenerative DiseasesProtein ConformationStem CellsNestinCentral and peripheral nervous systemsHematological malignanciesHematopoietic stem cell nicheMesenchymal stromal cellsMouse modelsNestinNeural stem and progenitor cellsNeurodegenerative diseases

Identifiers

PMID29541793
PMCPMC5948302
OpenAlexW2790807198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.